Immune-mediated tissue damage occurs in the first few days of suffering a stroke and is mainly attributed to brain-infiltrating, IL-17 releasing, γδ T cells which are largely positive for the chemokine receptor CCR6 as they trigger a highly conserved immune reaction. Here, IL17A is linked to Stroke.